|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 41214 |
FusionGeneSummary for USP9X_ANP32B |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: USP9X_ANP32B | Fusion gene ID: 41214 | Hgene | Tgene | Gene symbol | USP9X | ANP32B | Gene ID | 8239 | 10541 |
| Gene name | ubiquitin specific peptidase 9 X-linked | acidic nuclear phosphoprotein 32 family member B | |
| Synonyms | DFFRX|FAF|FAM|MRX99|MRXS99F | APRIL|PHAPI2|SSP29 | |
| Cytomap | Xp11.4 | 9q22.33 | |
| Type of gene | protein-coding | protein-coding | |
| Description | probable ubiquitin carboxyl-terminal hydrolase FAF-XDrosophila fat facets related, X-linkeddeubiquitinating enzyme FAF-Xfat facets in mammalsfat facets protein related, X-linkedhFAMubiquitin specific protease 9, X chromosome (fat facets-like Drosoph | acidic leucine-rich nuclear phosphoprotein 32 family member Bacidic (leucine-rich) nuclear phosphoprotein 32 family, member Bacidic protein rich in leucinesputative HLA-DR-associated protein I-2silver-stainable protein SSP29 | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q93008 | Q92688 | |
| Ensembl transtripts involved in fusion gene | ENST00000378308, ENST00000324545, | ENST00000339399, ENST00000473205, | |
| Fusion gene scores | * DoF score | 14 X 8 X 10=1120 | 6 X 6 X 3=108 |
| # samples | 15 | 7 | |
| ** MAII score | log2(15/1120*10)=-2.90046432644909 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/108*10)=-0.625604485218502 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: USP9X [Title/Abstract] AND ANP32B [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | USP9X | GO:0016579 | protein deubiquitination | 19135894 |
| Hgene | USP9X | GO:0030509 | BMP signaling pathway | 19135894 |
| Hgene | USP9X | GO:1901537 | positive regulation of DNA demethylation | 25944111 |
| Tgene | ANP32B | GO:0006334 | nucleosome assembly | 20538007 |
| Tgene | ANP32B | GO:0045596 | negative regulation of cell differentiation | 22705300 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BE254787 | USP9X | chrX | 41088649 | - | ANP32B | chr9 | 100745638 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000378308 | ENST00000339399 | USP9X | chrX | 41088649 | - | ANP32B | chr9 | 100745638 | + |
| 5CDS-intron | ENST00000378308 | ENST00000473205 | USP9X | chrX | 41088649 | - | ANP32B | chr9 | 100745638 | + |
| In-frame | ENST00000324545 | ENST00000339399 | USP9X | chrX | 41088649 | - | ANP32B | chr9 | 100745638 | + |
| 5CDS-intron | ENST00000324545 | ENST00000473205 | USP9X | chrX | 41088649 | - | ANP32B | chr9 | 100745638 | + |
Top |
FusionProtFeatures for USP9X_ANP32B |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| USP9X | ANP32B |
| Deubiquitinase involved both in the processing ofubiquitin precursors and of ubiquitinated proteins. May thereforeplay an important regulatory role at the level of protein turnoverby preventing degradation of proteins through the removal ofconjugated ubiquitin. Specifically hydrolyzes 'Lys-48'-, 'Lys-29'- and 'Lys-33'-linked polyubiquitins chains. Essentialcomponent of TGF-beta/BMP signaling cascade. Specificallydeubiquitinates monoubiquitinated SMAD4, opposing the activity ofE3 ubiquitin-protein ligase TRIM33. Deubiquitinates alkylationrepair enzyme ALKBH3. OTUD4 recruits USP7 and USP9X to stabilizeALKBH3, thereby promoting the repair of alkylated DNA lesions(PubMed:25944111). Regulates chromosome alignment and segregationin mitosis by regulating the localization of BIRC5/survivin tomitotic centromeres. Involved in axonal growth and neuronal cellmigration (PubMed:16322459, PubMed:18254724, PubMed:19135894,PubMed:24607389). {ECO:0000269|PubMed:16322459,ECO:0000269|PubMed:18254724, ECO:0000269|PubMed:19135894,ECO:0000269|PubMed:24607389, ECO:0000269|PubMed:25944111}. | Multifunctional protein working as a cell cycleprogression factor as well as a cell survival factor. Required forthe progression from the G1 to the S phase. Anti-apoptotic proteinwhich functions as a caspase-3 inhibitor. Has no phosphatase 2A(PP2A) inhibitor activity (By similarity). Exhibits histonechaperone properties, stimulating core histones to assemble into anucleosome. {ECO:0000250, ECO:0000269|PubMed:20538007}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for USP9X_ANP32B |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_USP9X_ENST00000378308_chrX_41088649_-_ANP32B_ENST00000339399_chr9_100745638_+_317aa LRSREXLGSGGSARLPARRPPPRTAPPASAASKPFRRPSLRKPGRLSPLRPRRGKLSLKRGEEGNMDMKRRIHLELRNRTPAAVRELVLD NCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECL KSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPDSDAEVDGVDEEEEDEEGEDEEDEDDEDGEEEEFDEEDDEDEDVEGDED >In-frame_USP9X_ENST00000324545_chrX_41088649_-_ANP32B_ENST00000339399_chr9_100745638_+_317aa LRSREXLGSGGSARLPARRPPPRTAPPASAASKPFRRPSLRKPGRLSPLRPRRGKLSLKRGEEGNMDMKRRIHLELRNRTPAAVRELVLD NCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECL KSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPDSDAEVDGVDEEEEDEEGEDEEDEDDEDGEEEEFDEEDDEDEDVEGDED |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_USP9X_ENST00000378308_chrX_41088649_-_ANP32B_ENST00000339399_chr9_100745638_+_951nt CTCCGCTCCCGTGAGTAACTTGGCTCCGGGGGCTCCGCTCGCCTGCCCGCACGCCGCCCGCCACCCAGGACCGCGCCGCCGGCCTCCGCC GCTAGCAAACCCTTCCGACGGCCCTCGCTGCGCAAGCCGGGACGCCTCTCCCCCCTCCGCCCCCGCCGCGGAAAGTTAAGTTTGAAGAGG GGGGAAGAGGGGAACATGGACATGAAGAGGAGGATCCACCTGGAGCTGAGGAACCGGACCCCGGCAGCTGTTCGAGAACTTGTCTTGGAC AATTGCAAATCAAATGATGGAAAAATTGAGGGCTTAACAGCTGAATTTGTGAACTTAGAGTTCCTCAGTTTAATAAATGTAGGCTTGATC TCAGTTTCAAATCTCCCCAAGCTGCCTAAATTGAAAAAGCTTGAACTCAGTGAAAATAGAATCTTTGGAGGTCTGGACATGTTAGCTGAA AAACTTCCAAATCTCACACATCTAAACTTAAGTGGAAATAAACTGAAAGATATCAGCACCTTGGAACCTTTGAAAAAGTTAGAATGTCTG AAAAGCCTGGACCTCTTTAACTGTGAGGTTACCAACCTGAATGACTACCGAGAGAGTGTCTTCAAGCTCCTGCCCCAGCTTACCTACTTG GATGGCTATGACCGAGAGGACCAGGAAGCACCTGACTCAGATGCCGAGGTGGATGGTGTGGATGAAGAGGAGGAGGACGAAGAAGGAGAA GATGAGGAAGACGAGGACGATGAGGATGGTGAAGAAGAGGAGTTTGATGAAGAAGATGATGAAGATGAAGATGTAGAAGGGGATGAGGAC GACGATGAAGTCAGTGAGGAGGAAGAAGAATTTGGACTTGATGAAGAAGATGAAGATGAGGATGAGGATGAAGAGGAGGAAGAAGGTGGG >In-frame_USP9X_ENST00000324545_chrX_41088649_-_ANP32B_ENST00000339399_chr9_100745638_+_951nt CTCCGCTCCCGTGAGTAACTTGGCTCCGGGGGCTCCGCTCGCCTGCCCGCACGCCGCCCGCCACCCAGGACCGCGCCGCCGGCCTCCGCC GCTAGCAAACCCTTCCGACGGCCCTCGCTGCGCAAGCCGGGACGCCTCTCCCCCCTCCGCCCCCGCCGCGGAAAGTTAAGTTTGAAGAGG GGGGAAGAGGGGAACATGGACATGAAGAGGAGGATCCACCTGGAGCTGAGGAACCGGACCCCGGCAGCTGTTCGAGAACTTGTCTTGGAC AATTGCAAATCAAATGATGGAAAAATTGAGGGCTTAACAGCTGAATTTGTGAACTTAGAGTTCCTCAGTTTAATAAATGTAGGCTTGATC TCAGTTTCAAATCTCCCCAAGCTGCCTAAATTGAAAAAGCTTGAACTCAGTGAAAATAGAATCTTTGGAGGTCTGGACATGTTAGCTGAA AAACTTCCAAATCTCACACATCTAAACTTAAGTGGAAATAAACTGAAAGATATCAGCACCTTGGAACCTTTGAAAAAGTTAGAATGTCTG AAAAGCCTGGACCTCTTTAACTGTGAGGTTACCAACCTGAATGACTACCGAGAGAGTGTCTTCAAGCTCCTGCCCCAGCTTACCTACTTG GATGGCTATGACCGAGAGGACCAGGAAGCACCTGACTCAGATGCCGAGGTGGATGGTGTGGATGAAGAGGAGGAGGACGAAGAAGGAGAA GATGAGGAAGACGAGGACGATGAGGATGGTGAAGAAGAGGAGTTTGATGAAGAAGATGATGAAGATGAAGATGTAGAAGGGGATGAGGAC GACGATGAAGTCAGTGAGGAGGAAGAAGAATTTGGACTTGATGAAGAAGATGAAGATGAGGATGAGGATGAAGAGGAGGAAGAAGGTGGG |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_USP9X_ENST00000378308_chrX_41088649_-_ANP32B_ENST00000339399_chr9_100745638_+_1463nt CTCCGCTCCCGTGAGTAACTTGGCTCCGGGGGCTCCGCTCGCCTGCCCGCACGCCGCCCGCCACCCAGGACCGCGCCGCCGGCCTCCGCC GCTAGCAAACCCTTCCGACGGCCCTCGCTGCGCAAGCCGGGACGCCTCTCCCCCCTCCGCCCCCGCCGCGGAAAGTTAAGTTTGAAGAGG GGGGAAGAGGGGAACATGGACATGAAGAGGAGGATCCACCTGGAGCTGAGGAACCGGACCCCGGCAGCTGTTCGAGAACTTGTCTTGGAC AATTGCAAATCAAATGATGGAAAAATTGAGGGCTTAACAGCTGAATTTGTGAACTTAGAGTTCCTCAGTTTAATAAATGTAGGCTTGATC TCAGTTTCAAATCTCCCCAAGCTGCCTAAATTGAAAAAGCTTGAACTCAGTGAAAATAGAATCTTTGGAGGTCTGGACATGTTAGCTGAA AAACTTCCAAATCTCACACATCTAAACTTAAGTGGAAATAAACTGAAAGATATCAGCACCTTGGAACCTTTGAAAAAGTTAGAATGTCTG AAAAGCCTGGACCTCTTTAACTGTGAGGTTACCAACCTGAATGACTACCGAGAGAGTGTCTTCAAGCTCCTGCCCCAGCTTACCTACTTG GATGGCTATGACCGAGAGGACCAGGAAGCACCTGACTCAGATGCCGAGGTGGATGGTGTGGATGAAGAGGAGGAGGACGAAGAAGGAGAA GATGAGGAAGACGAGGACGATGAGGATGGTGAAGAAGAGGAGTTTGATGAAGAAGATGATGAAGATGAAGATGTAGAAGGGGATGAGGAC GACGATGAAGTCAGTGAGGAGGAAGAAGAATTTGGACTTGATGAAGAAGATGAAGATGAGGATGAGGATGAAGAGGAGGAAGAAGGTGGG AAAGGTGAAAAGAGGAAGAGAGAAACAGATGATGAAGGAGAAGATGATTAAGACCCCAGATGACCTGCAGAAACAGAACTGTTCAGTATT GGTTGGACTGCTCATGGATTTTGTAGCTGTTTAAAAAAAAAAAAAAGGTAGCTGTGATACAAACCCCAGGACACCCACCCACCCAAAGAG CCAAAGAATAGTTCCTGTGACATTCCGCCTTCCTTCCATGTAGTCCCTCTTGGTAATCTACCACCAAGCTTGTGGACTTCACCCCAACAA AATTGTAAGCGTTGTTAGGTTTTTGTGTAAGATTCTTGCTGTAGCGTGGATAGCTGTGATTGGTGAGTCAACCGTCTGTGGCTACCAGTT ACACTGAGATTGTAACAGCATTTTTACTTTCTGTACAACAAAAAAGCTTTGTAAATAAAATCTTAACATTTTGGGTCTGTTTTTTCATGC TTTGCTTTTTAATTATTATTATTATTTTTTTTACATTAGGACATTTTATGTGACAACTGCCAAAAAAGTATTTTTAAGAATTTAAGCGAA >In-frame_USP9X_ENST00000324545_chrX_41088649_-_ANP32B_ENST00000339399_chr9_100745638_+_1463nt CTCCGCTCCCGTGAGTAACTTGGCTCCGGGGGCTCCGCTCGCCTGCCCGCACGCCGCCCGCCACCCAGGACCGCGCCGCCGGCCTCCGCC GCTAGCAAACCCTTCCGACGGCCCTCGCTGCGCAAGCCGGGACGCCTCTCCCCCCTCCGCCCCCGCCGCGGAAAGTTAAGTTTGAAGAGG GGGGAAGAGGGGAACATGGACATGAAGAGGAGGATCCACCTGGAGCTGAGGAACCGGACCCCGGCAGCTGTTCGAGAACTTGTCTTGGAC AATTGCAAATCAAATGATGGAAAAATTGAGGGCTTAACAGCTGAATTTGTGAACTTAGAGTTCCTCAGTTTAATAAATGTAGGCTTGATC TCAGTTTCAAATCTCCCCAAGCTGCCTAAATTGAAAAAGCTTGAACTCAGTGAAAATAGAATCTTTGGAGGTCTGGACATGTTAGCTGAA AAACTTCCAAATCTCACACATCTAAACTTAAGTGGAAATAAACTGAAAGATATCAGCACCTTGGAACCTTTGAAAAAGTTAGAATGTCTG AAAAGCCTGGACCTCTTTAACTGTGAGGTTACCAACCTGAATGACTACCGAGAGAGTGTCTTCAAGCTCCTGCCCCAGCTTACCTACTTG GATGGCTATGACCGAGAGGACCAGGAAGCACCTGACTCAGATGCCGAGGTGGATGGTGTGGATGAAGAGGAGGAGGACGAAGAAGGAGAA GATGAGGAAGACGAGGACGATGAGGATGGTGAAGAAGAGGAGTTTGATGAAGAAGATGATGAAGATGAAGATGTAGAAGGGGATGAGGAC GACGATGAAGTCAGTGAGGAGGAAGAAGAATTTGGACTTGATGAAGAAGATGAAGATGAGGATGAGGATGAAGAGGAGGAAGAAGGTGGG AAAGGTGAAAAGAGGAAGAGAGAAACAGATGATGAAGGAGAAGATGATTAAGACCCCAGATGACCTGCAGAAACAGAACTGTTCAGTATT GGTTGGACTGCTCATGGATTTTGTAGCTGTTTAAAAAAAAAAAAAAGGTAGCTGTGATACAAACCCCAGGACACCCACCCACCCAAAGAG CCAAAGAATAGTTCCTGTGACATTCCGCCTTCCTTCCATGTAGTCCCTCTTGGTAATCTACCACCAAGCTTGTGGACTTCACCCCAACAA AATTGTAAGCGTTGTTAGGTTTTTGTGTAAGATTCTTGCTGTAGCGTGGATAGCTGTGATTGGTGAGTCAACCGTCTGTGGCTACCAGTT ACACTGAGATTGTAACAGCATTTTTACTTTCTGTACAACAAAAAAGCTTTGTAAATAAAATCTTAACATTTTGGGTCTGTTTTTTCATGC TTTGCTTTTTAATTATTATTATTATTTTTTTTACATTAGGACATTTTATGTGACAACTGCCAAAAAAGTATTTTTAAGAATTTAAGCGAA |
Top |
FusionGenePPI for USP9X_ANP32B |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for USP9X_ANP32B |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for USP9X_ANP32B |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | USP9X | C3806746 | MENTAL RETARDATION, X-LINKED 99 | 1 | UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|